Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD

Jens T. Bakker, Jorine E. Hartman, Karin Klooster, Jean Paul Charbonnier, Michail Tsiaousis, Rozemarijn Vliegenthart, Dirk Jan Slebos*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Downloads (Pure)

Abstract

This study investigated the impact of bronchoscopic lung volume reduction treatment using endobronchial valves (EBV) on diaphragm configuration. We successfully analyzed the diaphragm index using a newly developed quantitative computed tomography (QCT) tool before and after EBV treatment in forty patients with severe emphysema. We evaluated whether changes in the diaphragm index were associated with improvements in forced expiratory volume in 1 s (FEV1), residual volume (RV), Saint Georges Respiratory Questionnaire (SGRQ), and 6-min walking distance (6MWD) using Spearman's rho. The EBV treatment influenced the diaphragm configuration only on the treated side, resulting in an increased diaphragm curvature. There were significant associations of relative diaphragm index changes on the treated lung side or the entire diaphragm with improvements in FEV1 and 6MWD. These findings provide valuable insights into how EBV treatment affects the diaphragm in COPD patients.

Original languageEnglish
Article number107856
Number of pages3
JournalRespiratory Medicine
Volume234
DOIs
Publication statusPublished - 1-Nov-2024

Fingerprint

Dive into the research topics of 'Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD'. Together they form a unique fingerprint.

Cite this